UAE Cardiac Resynchronization Therapy Market Report 2022 to 2030

UAE Cardiac Resynchronization Therapy Market

$ 3999

UAE Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $38 Mn by 2030 with a 6% CAGR. The increasing worldwide incidence of heart failure, propelled by aging demographics and cardiovascular diseases linked to lifestyle, emerges as a significant factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, prominent players in this market encompass Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.

ID: IN10AEPH443 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Dr. Medha Sansanwal

Buy Now

UAE Cardiac Resynchronization Therapy Market Executive Summary

UAE Cardiac Resynchronization Therapy Market valued at $24 Mn in 2022, projected to reach $38 Mn by 2030 with a 6% CAGR.

Cardiac resynchronization therapy (CRT) involves the use of a pacemaker to correct the heart's rhythm through a minor surgical procedure. Implanted beneath the skin, the CRT pacemaker is responsible for coordinating the timing between the upper (atria) and lower (ventricles) heart chambers, as well as synchronizing the left and right sides of the heart. This intervention is particularly crucial in cases of heart failure, where inadequate pumping results in fluid accumulation in the lungs and legs due to the asynchronous beating of the two lower chambers (ventricles). Additionally, in the presence of severe heart rhythm issues, a physician might suggest an implantable cardioverter-defibrillator (ICD), which can be combined with CRT therapy. The CRT device connects wires from the pacemaker to both sides of the heart, employing biventricular pacing to transmit electrical signals to the ventricles, ensuring coordinated contractions and optimizing overall heart function.

Heart disease, notably heart attacks, is the leading cause of mortality in the United Arab Emirates, responsible for over 40% of all deaths. There's a concerning rise in heart attacks among young adults. Coronary heart disease (CHD) contributes to 80% of cardiovascular disease (CVD) mortality, with Atherosclerotic Cardiovascular Disease (ASCVD) affecting about 40% of adult residents. Many are unaware of their risk until experience serious conditions like heart attacks or strokes. Ischemic heart disease accounts for 52% of male and 21% of female deaths in the UAE, despite comprising 16% of global fatalities.

The Sharjah Institute for Medical Research (SIMR) is collaborating with global partners to develop AI-driven algorithms for the early identification of cardiac rhythm disorders requiring pacemaker implantation. Meanwhile, the Abu Dhabi Telemedicine Centre has initiated a pilot program for remote monitoring of pacemaker patients, enabling real-time data transfer to healthcare providers. This innovative approach ensures prompt treatments and enhances patient outcomes, highlighting the potential of remote monitoring to improve pacemaker users' follow-up care.

Market Dynamics

Market Growth Drivers

Rising Prevalence of Cardiovascular Diseases (CVDs): The UAE's leading cause of death is cardiovascular disorders, with a notable emphasis on the frequency of heart attacks. In the United Arab Emirates, heart disease, particularly heart attacks are the leading cause of mortality, accounting for more than 40% of all fatalities. There is a direct correlation between the growing prevalence of this illness and the rising need for pacemakers. This rise in the need for pacemakers helps in the expansion of the cardiac resynchronization therapy market.

Technological Advancements: The increasing popularity of Cardiac Resynchronization Therapy (CRT) among both patients and physicians can be attributed to technological advancements. These include the development of smaller, more energy-efficient devices with prolonged battery life and advanced functionalities. Patient care is significantly enhanced through features such as remote monitoring and telemedicine capabilities, leading to better outcomes after implantation. The future outlook for CRT appears promising, especially with emerging technologies like leadless pacemakers and artificial intelligence-driven algorithms, indicating potential advancements in the field.

Increased Awareness and Education: Collaborative efforts between healthcare organizations and patient advocacy groups aim to elevate public awareness regarding heart failure and treatment alternatives such as CRT through public health campaigns and educational programs. Increased patient understanding and consciousness can lead to early diagnosis, prompt therapies, and better overall results in the long run.

Market Restraints

Regulatory obstacles: Stringent rules or delays in approving medical devices, including CRT devices, can create difficulties in entering the market and achieving growth. Medical device companies face complex regulatory requirements, and non-compliance can have significant impacts on costs and reputation. The challenge for regulatory bodies is to strike a balance between ensuring the safety and effectiveness of products without unduly slowing down the approval process.

High Cost of CRT Devices: The cost of CRT devices is considerable, varying from tens of thousands to hundreds of thousands of dollars. For patients, especially those with limited financial resources or inadequate insurance coverage, this large cost may provide a major challenge. Patients may have significant out-of-pocket costs even with insurance, which deters them from seeking CRT therapy.

Limited Access to Specialists: The implantation of CRT devices demands specific skills and training. The scarcity of trained electrophysiologists and other specialists, especially in locations outside major cities, may hinder many patients' access to this therapy.

Healthcare Policies and Regulatory Landscape

In the United Arab Emirates (UAE), the management of healthcare policies and regulatory control over treatment drugs is primarily overseen by key entities such as the Ministry of Health and Prevention (MOHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA), Emirates Health Services Establishment (EHSE), and the Pharmaceutical Services Department (PSD). MOHAP, serving as a central regulatory authority, plays a crucial role in the creation and implementation of healthcare policies, with a focus on ensuring the safety, effectiveness, and quality of pharmaceuticals. Additionally, regional health authorities like HAAD and DHA are responsible for overseeing healthcare services, including drug regulations, within their respective emirates. EHSE contributes to regulations at the federal level, and PSD, operating under MOHAP, concentrates on activities related to pharmaceuticals. The Centralized Procurement Office (CPO) is actively involved in the acquisition of pharmaceuticals for public healthcare facilities, with a commitment to maintaining adherence to regulatory standards.

Competitive Landscape

Key Players

Abbott
Boston Scientific
Medtronic
Siemens Healthineers
Johnson & Johnson
Biotronik
LivaNova
MicroPort
Sorin Group
St. Jude Medical

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UAE Cardiac Resynchronization Therapy Market Segmentation

By Product

CRT-Defibrillator
CRT-Pacemaker

By Age

Below 44 years
45-64 years
65-84 years
Above 85 years

By End-Users

Hospitals
Cardiac care Centres
Ambulatory Surgical Centres

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.